Dugel Pravin 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 26, 2024
Insider Transaction Report
Form 4
Dugel Pravin
DirectorSee Remarks
Transactions
- Award
Stock Option (Right to Buy)
2024-02-22+1,282,469→ 1,282,469 totalExercise: $9.70Exp: 2024-02-21→ Common Stock (1,282,469 underlying) - Award
Common Stock
2024-02-22+854,979→ 854,979 total
Footnotes (2)
- [F1]On February 22, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, in equal quarterly installments, beginning on the date of grant.
- [F2]Vests over four years, vesting in equal monthly installments beginning on the date the reporting person commenced employment with the Corporation.